James C. Edgemond
CFO & TreasurerMr. James C. Edgemond serves as Director of Miromatrix Medical Inc. since December 13, 2023. He has been the Chief Financial Officer and Treasurer of United Therapeutics Corporation since March 13, 2015 and January 2013 respectively. He was Vice President of Strategic Financial Planning at United Therapeutics Corporation from January 2013. He joined the United Therapeutics Corporation in January 2013. Prior to joining United Therapeutics, he was Vice President, Corporate Controller and Treasurer of Clark Construction Group from 2008 through January 2013. He has been a Director of SteadyMed Ltd. since August 30, 2018. He also served in a variety of roles at The Corporate Executive Board Company from 1998 to 2008, serving as Executive Director, Finance from 2005 to 2008. He serves as a Director of Perfusix USA, Inc. He also served in a variety of roles at The Corporate Executive Board Company from 1998 to 2008, including most recently as Executive Director, Finance from 2005 to 2008. Mr. Edgemond began his career as a public accountant at KPMG Peat Marwick LLP, where he served in a variety of roles from 1990 through 1998, including most recently as a Senior Manager.
Positions
- Company NameUnited Therapeutics CorporationStock CodeUTHRPositionCFO & TreasurerColleagues
- MAMartine A. RothblattFounder, Chairman & CEO
- MIMichael I. BenkowitzPresident & COO
- PAPaul A. MahonExecutive VP, General Counsel & Corporate Secretary
- HSHarrison SilversManager of Investor Relations
- CPChristopher PatuskyIndependent Vice Chairman & Lead Independent Director
- GGGil GoldenSenior VP, Chief Medical Officer & Member of the Scientific Advisory Board
- CCChristopher CauseyIndependent Director
- RGRichard GiltnerIndependent Director
